Phenformin hydrochloride

CAS No. 834-28-6

Phenformin hydrochloride( Phenformin Hydrochloride | Phenformin HCl | Meltrol | Dipar | Phenethylbiguanide hydrochloride | W-104144 )

Catalog No. M16091 CAS No. 834-28-6

Phenformin, an anti-diabetic drug, has demonstrated antitumor activity both in vitro and in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 39 In Stock

Biological Information

  • Product Name
    Phenformin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Phenformin, an anti-diabetic drug, has demonstrated antitumor activity both in vitro and in vivo.
  • Description
    Phenformin, an anti-diabetic drug, has demonstrated antitumor activity both in vitro and in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Phenformin Hydrochloride | Phenformin HCl | Meltrol | Dipar | Phenethylbiguanide hydrochloride | W-104144
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK| Potassium Channel
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    834-28-6
  • Formula Weight
    241.72
  • Molecular Formula
    C10H16ClN5
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 12 mg/mL (49.64 mM); Water: 48 mg/mL (198.57 mM); DMSO: 48 mg/mL (198.57 mM)
  • SMILES
    Cl.NC(N)=NC(N)=NCCC1=CC=CC=C1
  • Chemical Name
    1-(diaminomethylidene)-2-(2-phenylethyl)guanidine;hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sakamoto K, et al. Am J Physiol Endocrinol Metab, 2004, 287(2), E310-317.
molnova catalog
related products
  • AMPK activator 4

    AMPK activator 4 is a potent and selective AMPK activator that does not inhibit mitochondrial complex I.

  • AMPK activator 991

    AMPK activator 991 is an allosteric AMPK activator.

  • Aldometanib

    Aldometanib (LXY-05-029) is an orally active aldolase inhibitor that prevents FBP from binding to v-ATPase-associated aldolase and activates lysosomal AMPK, useful in metabolic homeostasis research .